The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Desensitization Still Achieved With Long-Term, Low-Dose Peanut OIT
Patients with a peanut allergy that can only tolerate low doses of oral immunotherapy can still achieve desensitization.
Synthetic Folic Acid In Utero Drives Food Allergies
The synthetic vitamin B9 is a common prenatal treatment to prevent birth defects, but may not be as safe as its natural form.
The Benefits of Fish Oil and Peanut Butter in Newborns, Children
While peanut butter exposure aids children from an early age, fish oil could improve asthma rates.
Is Indoor Home Intervention for Asthma Effective?
While the data have been met with conflicting opinions, environmental interventions for allergens in the home hold potential for asthma.
Claus Bachert, MD, PhD: Dupilumab for Nasal Polyps
The researcher from Ghent University in Belgium discussed the improved quality of life patient with severe nasal polyps experience with monoclonal antibodies.
Pre-Teen Growth May Be Affected by Cow's Milk Allergy
Persistent cow's milk allergy may negatively impact height, weight, and BMI through adolescence.
Mitigating the Effects of Pollutants on Disease
Policy interventions and medication are the best available methods for improving the negative impact pollutants have on patients.
How Allergists Can Work With Schools to Improve Asthma Care
Improving asthma management in schools not only benefits pediatric patients' health, but improves attendance rates.
Certain Blood Types Linked to Protective Benefit for Red Meat Allergy
Those with blood type B or AB are an estimated 5-fold less likely to be diagnosed with red meat allergy.
Eosinophilic Esophagitis Found to be Late Member of Atopic March
The condition was found to be linked in pediatric patients who already suffer from asthma, atopic dermatitis, or food allergies, and can lead to children developing allergic rhinitis.
Red Meat Allergy Patients 5 Times as Likely to Have Insect Allergy
New study results compound on previous evidence of an association between tick bites and red meat allergy.
Managing the Early Events of Childhood Asthma
Early allergen sensitization is associated with an increased risk of viral infections and the development of childhood asthma.
The Role of a Dietitian in Food Allergies
Alexia Beauregard, MS, RD, CSP, LD, explains how a food allergy specialist dietitian could make a life-saving difference in helping families understand food allergy.
The Dietitian's Role in Telehealth
As telehealth becomes more widely used, the role dietitians play in multidisciplinary teams for the treatment of allergy has increased.
FDA Accepts Dupilumab sBLA for Asthma Add-on Therapy
The FDA previously approved DUPIXENT in the US for the treatment of adults with moderate-to-severe atopic dermatitis.
Researching MPS Therapies with Dr. Patricia Dickson of LA BioMed
Patricia Dickson, M.D., discusses similarities between variations of MPS and the both the benefits and challenges of being a researcher in the rare disease community.
The Importance of Researcher Involvement in the Rare Disease Community
Alexy V. Pshezhetsky, Ph.D., professor at the University of Montreal. sits down at WORLDSymposium to stress the importance of researcher involvement throughout the rare disease community.
Discussing Shire's Rare Disease Pipeline with Hartmann Wellhoefer, M.D.
Hartmann Wellhoefer, M.D., head of medical affairs at Shire, sits down with RDR at the 14th Annual WORLDSymposium to discuss the company's recent data for lysosomal storage diseases.
A Sense of Urgency in Sanfilippo Therapy Development
With no real standard-of-care for Sanfilippo syndrome patients, Brian Bigger, Ph.D., discusses the sense of urgency he and his colleagues feel while researching.
Interim Data of Sanflippo B Treatment Presented at WORLDSymposium
BioMarin presented interim data at the 14th Annual WORLDSymposium in San Diego from a Phase 1/2 trial for BMN 250 in MPS IIIB.
ArmaGen Intends to Start Phase 3 of AGT-181 in MPS I
ArmaGen reported full 52-week results from a Phase 2 proof-of-concept study with AGT-181 in MPS I.
Are Gaucher Disease and Parkinsons Linked?
Rare Disease Report sits down with Simon Heales, Ph.D., Professor of Clinical Chemistry at Great Ormond Street Children’s Hospital in London who discusses a potential link between Gaucher disease and Parkinson’s disease.
Sanofi Presents Safety Data from Phase 1/2 in Pompe
Sanofi Genzyme presented results from the Phase 1/2 trial, showing consistent safety data for the investigational avalglucosidase alfa in late-onset Pompe disease.
Amicus Releases More Positive Data at WORLDSymposium
Amicus presented additional positive results from the company’s Phase 1/2 clinical study of ATB200/AT2221 in patients with Pompe disease in a late-breaker poster and a corresponding oral presentation.
Valerion Presents Data from Study of VAL-1221 in Pompe Disease
Today at the WORLDSymposium in San Diego, Valerion Therapeutics presented initial results from the first cohort of its ongoing Phase 1/2 clinical study of VAL-1221 in patients with late-onset Pompe disease.
Interim Data of Kanuma in LAL-D Infants Presented at WORLDSymposium
At the 14th Annual WORLDSymposium, interim data from two open-label studies were presented, exhibiting a 3-year survival estimate of 68% in infants with rapidly progressing LAL-D treated with sebelipase alfa.
Nathan Radcliffe, MD: New Surgical Instrument Allows for Simultaneous Cataract and Glaucoma Surgery
Kahook Dual Blade intends to reduce intraocular pressure and the number of patient medications.
AMD Stem Cell Therapy Shows Potential for Vision Gain
The retinal injection therapy could be capable of replacing damaged cells integral to eye vision.
John Shepherd, MD: Recognizing and Addressing Depression in Low Vision Patients
Depression has been shown in research studies to correlate with the level of disability.
Carl Awh, MD: Human Experience of Hypersonic Vitrectomy
This new technology allows for smaller gauge with flow rate similar to that of the guillotine-based one.